Botulinum toxin type A and progressive pneumoperitoneum for loss-of-domain hernia: a narrative review
DOI:
https://doi.org/10.18203/2320-6012.ijrms20261725Keywords:
Incisional hernia, Loss of domain, Botulinum toxin A, Pneumoperitoneum, Conditioning, ProgressiveAbstract
The management of incisional hernias with loss of domain (LOD) represents a significant surgical challenge. Preoperative conditioning with botulinum toxin type A (BTX-A) and preoperative progressive pneumoperitoneum (PPP) has emerged as an effective strategy in specialized centers. To synthesize the available evidence on the pathophysiological basis, clinical and volumetric indications, and outcomes of the combined use of BTX-A and PPP in hernias with LOD. A narrative review of the literature was conducted through searches in PubMed, SciELO, and Scopus, including studies related to the pathophysiological basis, indications, technical aspects, and clinical outcomes of BTX-A and PPP in hernias with LOD. The combination of BTX-A and PPP produces elongation of the lateral abdominal muscles, reduces the hernia defect, and induces adaptive volumetric expansion of the abdominal cavity through progressive insufflations. When applied 15-30 days before surgery, these interventions allow primary fascial closure rates approaching or exceeding 95%. However, adequate patient selection based on volumetric and clinical criteria, while considering potential complications, is essential. The evidence available to date suggests that the combined use of BTX-A and PPP optimizes fascial closure in complex hernias, with high efficacy in experienced centers. However, the evidence remains limited to observational studies; therefore, protocol standardization and controlled clinical trials are required to increase the level of evidence and allow this sequential therapeutic method to become a standard of care in routine clinical practice.
References
Deerenberg EB, Henriksen NA, Antoniou GA, Antoniou SA, Bramer WM, Fischer JP, et al. Updated guideline for closure of abdominal wall incisions from the European and American Hernia Societies. BJS. 2022;109(12):1239-50.
Ahsan A, Nour HM, Peristeri D V., Abogabal S, Swaminathan C, Sajid MS. Systematic review with meta-analysis of transverse vs. vertical midline extraction incisional hernia risk following laparoscopic colorectal resections. Transl Gastroenterol Hepatol. 2023;8(0):NA.
Fortelny RH, Dietz U. [Incisional hernias: epidemiology, evidence and guidelines]. Chirurgie (Heidelberg, Germany). 2024;95(1):3-9.
Rhemtulla IA, Hsu JY, Broach RB, Mauch JT, Serletti JM, DeMatteo RP, et al. The incisional hernia epidemic: evaluation of outcomes, recurrence, and expenses using the healthcare cost and utilization project (HCUP) datasets. Hernia. 2021;25(6):1667-75.
Toma M, Oprea V, Grad ON, Pavel A, Kovacs H, Molnar C. Incisional Hernias with Loss of Abdominal Domain: A New Look to an Older Issue or the Elephant in the Living Room. Literature Review. Chirurgia (Bucur). 2022;117(1):5-13.
Parker SG, Halligan S, Blackburn S, Plumb AAO, Archer L, Mallett S, et al. What Exactly is Meant by “Loss of Domain” for Ventral Hernia? Systematic Review of Definitions. World J Surg. 2018;43(2):396-404.
Kirkpatrick AW, Nickerson D, Roberts DJ, Rosen MJ, McBeth PB, Petro CC, et al. Intra-Abdominal Hypertension and Abdominal Compartment Syndrome after Abdominal Wall Reconstruction: Quaternary Syndromes? Scand J Surg. 2017;106(2):97-106.
Parker SG, Halligan S, Liang MK, Muysoms FE, Adrales GL, Boutall A, et al. Definitions for Loss of Domain: An International Delphi Consensus of Expert Surgeons. World J Surg. 2019;44(4):1070-8.
Sabbagh C, Dumont F, Fuks D, Yzet T, Verhaeghe P, Regimbeau JM. Progressive preoperative pneumoperitoneum preparation (the Goni Moreno protocol) prior to large incisional hernia surgery: volumetric, respiratory and clinical impacts. A prospective study. Hernia. 2011;16(1):33-40.
van Rooijen MMJ, Yurtkap Y, Allaeys M, Ibrahim N, Berrevoet F, Lange JF. Fascial closure in giant ventral hernias after preoperative botulinum toxin a and progressive pneumoperitoneum: A systematic review and meta-analysis. Surgery (United States). 2021;170(3):769-76.
Bueno-Lledó J, Carreño-Saenz O, Torregrosa-Gallud A, Pous-Serrano S. Preoperative Botulinum Toxin and Progressive Pneumoperitoneum in Loss of Domain Hernias-Our First 100 Cases. Front Surg. 2020;7:3.
Obi M, Beffa L, Melland-Smith M, Messer N, Kanters A, Judeeba S, et al. The rate of ileostomy site incisional hernias: more common than we think? Hernia. 2024;28(6):2311-20.
Bueno-Lledó J, Torregrosa A, Ballester N, Carreño O, Carbonell F, Pastor PG, et al. Preoperative progressive pneumoperitoneum and botulinum toxin type A in patients with large incisional hernia. Hernia. 2017;21(2):233-43.
Giuffrida M, Biolchini F, Capelli P, Banchini F, Perrone G. Botulinum Toxin and Progressive Pneumoperitoneum in Loss of Domain Ventral Hernias: A Systematic Review. J Abdominal Wall Surg. 2024;3:12650.
Ibarra-Hurtado TR, Nuño-Guzmán CM, Miranda-Díaz AG, Troyo-Sanromán R, Navarro-Ibarra R, Bravo-Cuéllar L. Effect of botulinum toxin type A in lateral abdominal wall muscles thickness and length of patients with midline incisional hernia secondary to open abdomen management. Hernia. 2014;18(5):647-52.
Deerenberg EB, Elhage SA, Raible RJ, Shao JM, Augenstein VA, Heniford BT, et al. Image-guided botulinum toxin injection in the lateral abdominal wall prior to abdominal wall reconstruction surgery: review of techniques and results. Skeletal Radiol. 2021;50(1):NA.
Licari L, Campanella S, Carolla C, Madonia C, Canino B, Salamone G. Abdominal wall incisional hernia repair improves respiratory function: results after 3 years of follow-up. Hernia. 2020;25(4):999-1004.
Elstner KE, Read JW, Rodriguez-Acevedo O, Ho-Shon K, Magnussen J, Ibrahim N. Preoperative progressive pneumoperitoneum complementing chemical component relaxation in complex ventral hernia repair. Surg Endoscopy. 2016;31(4):1914-22.
Renard Y, Lardière-Deguelte S, de Mestier L, Appere F, Colosio A, Kianmanesh R, et al. Management of large incisional hernias with loss of domain: A prospective series of patients prepared by progressive preoperative pneumoperitoneum. Surgery. 2016;160(2):426-35.
Nasa P, Wise RD, Smit M, Acosta S, D’Amours S, Beaubien-Souligny W, et al. International cross-sectional survey on current and updated definitions of intra-abdominal hypertension and abdominal compartment syndrome. World J Emerg Surg. 2024;19(1):39.
Petro CC, Raigani S, Fayezizadeh M, Rowbottom JR, Klick JC, Prabhu AS, et al. Permissible Intraabdominal Hypertension following Complex Abdominal Wall Reconstruction. Plast Reconstr Surg. 2015;136(4):868-81.
Tanaka EY, Yoo JH, Rodrigues AJ, Utiyama EM, Birolini D, Rasslan S. A computerized tomography scan method for calculating the hernia sac and abdominal cavity volume in complex large incisional hernia with loss of domain. Hernia. 2010;14(1):63-9.
Sabbagh C, Dumont F, Robert B, Badaoui R, Verhaeghe P, Regimbeau JM. Peritoneal volume is predictive of tension-free fascia closure of large incisional hernias with loss of domain: a prospective study. Hernia. 2011;15(5):559-65.
Yurtkap Y, van Rooijen MMJ, Roels S, Bosmans JML, Uyttebroek O, Lange JF, et al. Implementing preoperative Botulinum toxin A and progressive pneumoperitoneum through the use of an algorithm in giant ventral hernia repair. Hernia. 2020;25(2):389-98.
Van Hoef S, Dries P, Allaeys M, Eker HH, Berrevoet F. Intra-abdominal hypertension and compartment syndrome after complex hernia repair. Hernia. 2024;28(3):701-9.
Martínez-Hoed J, Bonafe-Diana S, Bueno-Lledó J. A systematic review of the use of progressive preoperative pneumoperitoneum since its inception. Hernia. 2021;25(6):1443-58.
Bueno-Lledó J, Torregrosa Gallud A, Jiménez Rosellón R, Carbonell Tatay F, García Pastor P, Bonafé Diana S, et al. Preoperative preparation of hernia with loss of domain: progressive pneumoperitoneum and botulinum toxin type A. Cir Esp. 2017;95(5):245-53.
Rodriguez-Acevedo O, Elstner KE, Jacombs ASW, Read JW, Martins RT, Arduini F, et al. Preoperative Botulinum toxin A enabling defect closure and laparoscopic repair of complex ventral hernia. Surg Endosc. 2018;32(2):831-9.
Mancini A, Mougin N, Venchiarutti V, Shen Z, Risse O, Abba J, et al. Goni Moreno progressive preoperative pneumoperitoneum for giant hernias: a monocentric retrospective study of 162 patients. Hernia. 2020;24(3):545-50.
Zwaans WAR, Timmer AS, Boermeester MA. Preoperative Botulinum Toxin-A Injections Prior to Abdominal Wall Reconstruction Can Lead to Cardiopulmonary Complications. J Abdominal Wall Surg. 2024;3.
López-Juárez SE, Medina-Benítez A, Durán-Reyes R, Bagundo-Pérez BI, Fortuna-Sandoval OI, Trejo-García MS. Botulinum toxin A (IncobotulinumtoxinA) and pneumoperitoneum image-guided for hernia repair with loss of dominance. Cir Cir. 2023;91(1):117-21.
Timmer AS, Claessen JJM, Atema JJ, Rutten MVH, Hompes R, Boermeester MA. A systematic review and meta-analysis of technical aspects and clinical outcomes of botulinum toxin prior to abdominal wall reconstruction. Hernia. 2021;25(6):1413.
Tashkandi A, Bueno-Lledó J, Durtette-Guzylack J, Cayeux A, Bukhari R, Rhaeim R, et al. Adjunct botox to preoperative progressive pneumoperitoneum for incisional hernia with loss of domain: no additional effect but may improve outcomes. Hernia. 2021;25(6):1507-17.
Bueno-Lledó J, Martinez-Hoed J, Torregrosa-Gallud A, Menéndez-Jiménez M, Pous-Serrano S. Botulinum toxin to avoid component separation in midline large hernias. Surgery (United States). 2020;168(3):543-9.
Downloads
Published
How to Cite
Issue
Section
